Phathom Pharmaceuticals Inc (PHAT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 135,156 | 149,569 | 212,315 | 297,263 | 334,678 |
| Receivables | 55,789 | 51,255 | 36,364 | 38,797 | 21,052 |
| Inventories | 3,611 | 3,431 | 3,166 | 3,208 | 3,111 |
| TOTAL | $207,783 | $218,875 | $264,900 | $360,134 | $373,821 |
| Non-Current Assets | |||||
| PPE Net | 1,156 | 1,242 | 1,354 | 1,476 | 1,655 |
| Other Non-Current Assets | 31,350 | 30,103 | 27,954 | 16,708 | 11,568 |
| TOTAL | $32,506 | $31,345 | $29,308 | $18,184 | $13,223 |
| Total Assets | $240,289 | $250,220 | $294,208 | $378,318 | $387,044 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,075 | 4,008 | 11,617 | 10,507 | 7,133 |
| Accrued Expenses | 67,113 | 66,051 | 44,831 | 54,943 | 37,281 |
| Other current liabilities | 24,344 | 21,526 | 17,268 | 19,777 | 20,194 |
| TOTAL | $93,123 | $91,823 | $74,032 | $85,728 | $65,288 |
| Non-Current Liabilities | |||||
| Long Term Debt | 207,093 | 205,139 | 203,245 | 201,409 | 175,729 |
| Other Non-Current Liabilities | 362,607 | 359,092 | 355,307 | 344,761 | 333,139 |
| TOTAL | $569,700 | $564,231 | $558,552 | $546,170 | $508,868 |
| Total Liabilities | $662,823 | $656,054 | $632,584 | $631,898 | $574,156 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 71,138 | 70,944 | 69,814 | 69,637 | 68,377 |
| Common Shares | 6 | 6 | 6 | 6 | 6 |
| Retained earnings | -1,463,110 | -1,433,137 | -1,357,327 | -1,263,011 | -1,188,560 |
| TOTAL | $-422,534 | $-405,834 | $-338,376 | $-253,580 | $-187,112 |
| Total Liabilities And Equity | $240,289 | $250,220 | $294,208 | $378,318 | $387,044 |